Product Liability

New York Times: Company knowingly sold defective implants

Johnson & Johnson executives decided to phase out a replacement hip joint and sell its remaining inventory to be surgically implanted in patients just weeks after the company got a letter from the Food and Drug Administration about serious safety concerns with the devices.

The Times cites documents it attained under the Freedom of Information Act.

A report in the New York Times says that after receiving the letter, company executives waited a year to take the DePuy hip implants off the ...

continue reading...

Mother who lost job from implant wants reforms

A mother of three who had to quit her truck-driving job because of debilitating pain from a faulty vaginal mesh implant spoke up on Thursday, calling for federal lawmakers to close the loophole that allowed the implant to go on the market in the first place.

“It’s a question of loss,” said Colorado resident Jay Nevarez. “I lost my job and my health, and am in the process of losing my home.”

According to a report in The Boston Globe, Nevarez joined ...

continue reading...

Bloomberg: J&J sold mesh implant before FDA approval

According to a Bloomberg report, Johnson & Johnson sold a vaginal mesh implant for three years before the federal Food and Drug Administration approved the device.

The report says Johnson & Johnson introduced the Gynecare Prolift device in March 2005 without appropriate clearance. The FDA learned of the device in 2007 when Johnson & Johnson was trying to get approval for a related device.

The FDA approved both devices in 2008, after Johnson & Johnson took advantage of a loophole that obliges ...

continue reading...

NPR broadcast examines faulty hip implants

National Public Radio’s “Morning Edition” on Monday provided an in-depth look at the problems that recipients of DePuy’s all-metal hip implants are dealing with. The company recalled the implants in 2010 because of a high early failure rate.

The broadcast actually went into the operating room at Boston’s Massachusetts General Hospital, where New Hampshire resident Susy Mansfield was undergoing surgery to remove one of the faulty devices.

The surgeon described for listeners the dead muscle and the staining on Mansfield’s tissue from ...

continue reading...

Departing Johnson & Johnson CEO Weldon getting $143.5 million

Departing Johnson & Johnson Chief Executive Officer William C. Weldon, who is leaving after a spate of disastrous recalls, will get $143.5 million in retirement pay, according to Bloomberg.

Bloomberg reports that Weldon, 63, will remain chairman. He amassed $95.1 million in deferred and long-term compensation during his 40 years with the company, and his pension has a present value of $48.4 million.

The report mentions that the company struggled with recalls of artificial hip implants and over-the-counter drugs, and safety concerns ...

continue reading...

Women at particular risk from faulty hip implants

Although metal-on-metal hip implants have high failure rates for both sexes, women in particular have suffered from receiving the faulty devices, according to a report in the Guardian.

U.K. joint replacement experts called for the metal-on-metal implants – where both the ball and socket are coated in metal – to be banned following the medical journal Lancet’s release of a report earlier this week finding “unequivocal evidence” of high early failure rates.

The research, based on the National Joint Registry of England ...

continue reading...
Page 118 of 132 «...90100110116117118119120...»